NASDAQ:EXEL
Exelixis Stock News
$23.70
+0.170 (+0.722%)
At Close: Apr 26, 2024
Exelixis (NASDAQ:EXEL) Hits New 52-Week High at $27.08
12:22pm, Wednesday, 29'th Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) hit a new 52-week high on Monday . The company traded as high as $27.08 and last traded at $26.58, with a volume of 98687 shares. The stock had previously closed at $26.53
Earnings Preview: Exelixis (EXEL) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Apr 2020
Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Exelixis (EXEL) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Apr 2020
Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 27)
AstraZeneca plc (NYSE: AZN...
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by EULAV Asset Management
09:50am, Tuesday, 28'th Apr 2020
EULAV Asset Management boosted its position in shares of Exelixis, Inc. (NASDAQ:EXEL) by 16.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm own
Exelixis, Inc. (NASDAQ:EXEL) EVP Patrick J. Haley Sells 5,000 Shares of Stock
09:10am, Tuesday, 28'th Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) EVP Patrick J. Haley sold 5,000 shares of the firm’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $26.00, for a total transa
Exelixis, Inc. (NASDAQ:EXEL) Director George A. Scangos Sells 15,000 Shares of Stock
08:10am, Tuesday, 28'th Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) Director George A. Scangos sold 15,000 shares of the stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $26.24, for a
Earnings Preview: Exelixis (EXEL) Q1 Earnings Expected to Decline
12:00am, Tuesday, 28'th Apr 20202 Oncology Names That Are 'En Fuego'
08:59pm, Monday, 27'th Apr 2020
Today, we update the investment thesis on two oncology concerns whose stocks have been on fire here in April despite the continued COVID-19 outbreak. We recap w
EXEL or RGEN: Which Is the Better Value Stock Right Now?
03:40pm, Monday, 27'th Apr 2020
EXEL vs. RGEN: Which Stock Is the Better Value Option?
Stocks That Hit 52-Week Highs On Monday
02:21pm, Monday, 27'th Apr 2020
During Monday's morning session, these companies made new 52-week highs.
Noteworthy Points:
The largest company by market cap to set a new 52-week high was Novo Nordisk...
Exelixis, Inc. (NASDAQ:EXEL) Given Average Recommendation of "Buy" by Brokerages
10:42am, Monday, 27'th Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) has been assigned an average recommendation of “Buy” from the seventeen analysts that are presently covering the company, MarketBeat.com reports. Five research analyst
Exelixis, Inc. (NASDAQ:EXEL) CMO Gisela Schwab Sells 100,000 Shares
08:24am, Monday, 27'th Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) CMO Gisela Schwab sold 100,000 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $26.00, for a total tr